PCM
ABBV icon

Polymer Capital Management’s AbbVie ABBV Stock Holding History

Polymer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
+1,050
New +$226K 0.04% 534
2026
Q1 		– Sell
-2,160
Closed -$494K – 806
2025
Q4 		$494K Buy
2,160
+683
+46% +$156K 0.05% 467
2025
Q3 		$342K Buy
+1,477
New +$301K 0.04% 574

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Polymer Capital Management's ABBV Position: Q2 2026 in Review

Polymer Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 1,050 shares worth $264K. The stake represents 0.04% of the portfolio and ranks #534 among its holdings. This is a return to the name: Polymer Capital Management previously reported a position in ABBV as recently as Q4 2025.

Polymer Capital Management first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $494K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Polymer Capital Management held 1,050 shares of AbbVie worth $264K as of Q2 2026.
  • AbbVie was a new Polymer Capital Management position in Q2 2026.
  • AbbVie made up 0.04% of Polymer Capital Management's portfolio in Q2 2026, its #534 holding.
  • Polymer Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • Polymer Capital Management's AbbVie position peaked at $494K in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.